PulseExploreJournal ClubDebatesTrendingResearchersJournals
Instagram
HomeExploreJournal ClubTrending
Synapse
⌘+K
Synapse
February 8, 2026Expert Review of Anticancer Therapy2 citations

The evolving survival landscape in advanced non-small cell lung cancer: an interrupted time series analysis

View Full Paper
JJJianwei JiTLTaoying LiZLZhanwu Li

Key Points

  • This analysis aims to understand survival changes in advanced non-small cell lung cancer with new therapies.
  • Conducted an interrupted time series analysis
  • Examined survival data in adenocarcinoma
  • Compared treatment effectiveness across different patient subgroups
  • Significant survival improvements noted with targeted therapy and immunotherapy
  • Immunotherapy showed the most pronounced survival benefits
  • Variability in treatment efficacy across subgroups highlights the importance of personalized therapy

Abstract

The introduction of targeted therapy and immunotherapy has produced significant survival improvement in adenocarcinoma, with the most pronounced benefits in immunotherapy. Treatment efficacy varies across subgroups highlighting the need for further investigation to optimize personalized therapy.

Ask AI
Helpful
Bookmark
Share
View Full Paper

Cite This Study

Ji et al. (2026) studied this question.

synapsesocial.com/papers/698827570fc35cd7a8846092https://doi.org/10.1080/14737140.2026.2628946
Ask AI
Helpful
Bookmark
Share
View Full Paper